These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The management of chemotherapy-induced nausea and vomiting. Gralla RJ; Tyson LB; Kris MG; Clark RA Med Clin North Am; 1987 Mar; 71(2):289-301. PubMed ID: 3546981 [TBL] [Abstract][Full Text] [Related]
5. Rolapitant approved for chemotherapy-induced nausea and vomiting. Traynor K Am J Health Syst Pharm; 2015 Nov; 72(21):1838. PubMed ID: 26490812 [No Abstract] [Full Text] [Related]
6. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy. Hartvig P J Oncol Pharm Pract; 2007 Mar; 13(1):57-8. PubMed ID: 17621570 [No Abstract] [Full Text] [Related]
8. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting. Cope D Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282 [No Abstract] [Full Text] [Related]
9. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Natale JJ Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912 [TBL] [Abstract][Full Text] [Related]
10. Fighting nausea in the '90s: more and better anti-emetics can help. Saphir A J Natl Cancer Inst; 1997 Sep; 89(17):1252-5. PubMed ID: 9293911 [No Abstract] [Full Text] [Related]
11. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting. Spitzer TR; Grunberg SM; Dicato MA Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875 [TBL] [Abstract][Full Text] [Related]
12. [Gastrointestinal complication of cancer chemotherapy]. Hamaguchi T Nihon Rinsho; 2007 Oct; 65 Suppl 8():281-6. PubMed ID: 18074549 [No Abstract] [Full Text] [Related]
13. The pathophysiology of chemotherapy-induced nausea and vomiting. Baker PD; Morzorati SL; Ellett ML Gastroenterol Nurs; 2005; 28(6):469-80. PubMed ID: 16418583 [TBL] [Abstract][Full Text] [Related]
14. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods. Mahesh R; Perumal RV; Pandi PV Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895 [TBL] [Abstract][Full Text] [Related]
15. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice. Antonarakis ES; Hain RD Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871 [TBL] [Abstract][Full Text] [Related]
16. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Morrow GR; Roscoe JA; Kirshner JJ; Hynes HE; Rosenbluth RJ Support Care Cancer; 1998 May; 6(3):244-7. PubMed ID: 9629877 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain. Sutton IR; Daeninck P J Support Oncol; 2006; 4(10):531-5. PubMed ID: 17136871 [No Abstract] [Full Text] [Related]
19. [The prevention and treatment of nausea and vomiting during cancer chemotherapy]. Shparyk IaV; Bilyns'kyÄ BT; Koval'chuk IV; Petriv RM; Kachmar TB; Ohorchak MA Lik Sprava; 1997; (4):148-52. PubMed ID: 9471361 [TBL] [Abstract][Full Text] [Related]
20. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients? de Wit R; Aapro M; Blower PR Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]